Publications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: 10-Year Outcomes of the FLAME Trial.

01-10-2025

Biophysical journal

Long-read nucleosome mapping of single chromatin fibers using DNA methylation and nanopore sequencing.

01-10-2025

Magma (New York, N.Y.)

Beyond Gleason grading: MRI radiomics to differentiate cribriform growth from non-cribriform growth in prostate cancer men.

01-10-2025

European journal of cancer (Oxford, England : 1990)

Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database.

01-10-2025

Breast (Edinburgh, Scotland)

Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model.

01-10-2025

Molecular oncology

Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancer.

01-10-2025

Clinical cancer research : an official journal of the American Association for Cancer Research

Checkpoint Blockade Combinations in High Tumor Mutational Burden/Load Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in DRUP.

01-10-2025

European journal of cancer (Oxford, England : 1990)

Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial.

01-10-2025

Nature methods

Automated classification of cellular expression in multiplexed imaging data with Nimbus.

01-10-2025

Therapeutic drug monitoring

Clinical Application of Volumetric Absorptive Microsampling for Therapeutic Drug Monitoring of Oral Targeted Anticancer Drugs.

01-10-2025

European urology

Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial.

01-10-2025

Communications medicine

Clinical, pathological and molecular characteristics of patients with disease recurrence despite pathologic response to neoadjuvant ipilimumab plus nivolumab in stage III melanoma.

30-09-2025

Proceedings of the National Academy of Sciences of the United States of America

CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma.

30-09-2025

Clinical pharmacokinetics

Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study.

30-09-2025

Nature communications

Reanalysis of in vivo drug synergy validation study rules out synergy in most cases.

30-09-2025

European urology oncology

Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.

30-09-2025

Sleep

Quantifying cumulative circadian disruption from shift work and associations with health outcomes in a large cohort of nurses.

26-09-2025

PloS one

Association of ageing-related biomarkers with peripheral neuropathy in colorectal cancer patients up to 2 years after diagnosis.

26-09-2025

Cancer discovery

Microbial metabolic pathways guide response to immune checkpoint blockade therapy.

25-09-2025

Insights into imaging

Image-guided biopsy of breast lesions-when to use what biopsy technique.

25-09-2025

Nature medicine

Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial.

24-09-2025

Nucleic acids research

Coordinated control of genome-nuclear lamina interactions by topoisomerase 2B and lamin B receptor.

23-09-2025

Nucleic acids research

DNA polymerase kappa is the primary translesion synthesis polymerase for aldehyde ICLs.

23-09-2025

BMJ open

Perspectives on the treatment of sequela from cancer: a qualitative interview study of primary care physiotherapists.

22-09-2025

Nature reviews. Immunology

Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape.

22-09-2025

iScience

A 3D genome compendium of breast cancer progression.

19-09-2025

STAR protocols

Protocol for multiplexed transcription factor activity detection using optimized barcoded reporters and an automated computational pipeline.

19-09-2025

Functional maps of a genomic locus reveal confinement of an enhancer by its target gene

18-09-2025

Science (New York, N.Y.)

Functional maps of a genomic locus reveal confinement of an enhancer by its target gene.

18-09-2025

Clinical cancer research : an official journal of the American Association for Cancer Research

Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.

15-09-2025

Journal of cell science

The integrin odyssey - a journey full of fundamental discoveries.

15-09-2025

The British journal of radiology

Optimising Diagnostic Pathways through digital Multidisciplinary Team management of Patients with Cancer of Unknown Primary: a Retrospective Analysis.

13-09-2025

European journal of cancer (Oxford, England : 1990)

The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma.

09-09-2025

Current oncology (Toronto, Ont.)

'What Really Goes on in My Cancer Bubble, They Cannot Understand': Social Functioning Among Adolescent and Young Adult (AYA) Cancer Patients.

09-09-2025

Blood advances

BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants.

09-09-2025

Nature communications

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

08-09-2025

Journal of cancer survivorship : research and practice

Associations of adherence to the World Cancer Research Fund lifestyle recommendations with health-related quality of life and fatigue in Adolescent and Young Adult (AYA) cancer survivors: results from the SURVAYA study.

08-09-2025

Nucleic acids research

Profiling BRCA1-BRCT interactions and their functional relevance at amino acid resolution.

05-09-2025

Clinical cancer research : an official journal of the American Association for Cancer Research

Prognosis and biological characteristics of ER-low metastatic breast cancer: results from a multicenter cohort and the TONIC trial.

04-09-2025

World journal of urology

Routine annual imaging does not aid in diagnosing new functional complications more than five years after RC with ileal conduit.

03-09-2025

The British journal of surgery

Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial.

02-09-2025

BJU international

Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer.

02-09-2025

Cancer research

The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.

02-09-2025

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Night Shift Work and Risk of Melanoma: A Prospective Cohort Study among 59,384 Female Nurses in the Netherlands.

02-09-2025

Nature medicine

Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.

01-09-2025

Immuno-oncology technology

Comprehensive analysis of the systemic immune landscape across breast cancer subtypes and disease stages.

01-09-2025

Journal of the National Cancer Institute. Monographs

Exercise oncology comes of age.

01-09-2025

Nature

NASP modulates histone turnover to drive PARP inhibitor resistance.

01-09-2025

Trends in cell biology

Unlocking the signaling potential of GPI-anchored proteins through lipolytic cleavage.

01-09-2025

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Comparing adaptive and dose redistributed radiotherapy to conventional radiotherapy in head and neck cancer - Quality of life results from the phase III ARTFORCE trial.

01-09-2025

Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: 10-Year Outcomes of the FLAME Trial.

Long-read nucleosome mapping of single chromatin fibers using DNA methylation and nanopore sequencing.

Beyond Gleason grading: MRI radiomics to differentiate cribriform growth from non-cribriform growth in prostate cancer men.

Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database.

Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model.

Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancer.

Checkpoint Blockade Combinations in High Tumor Mutational Burden/Load Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in DRUP.

Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial.

Automated classification of cellular expression in multiplexed imaging data with Nimbus.

Clinical Application of Volumetric Absorptive Microsampling for Therapeutic Drug Monitoring of Oral Targeted Anticancer Drugs.

Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial.

Clinical, pathological and molecular characteristics of patients with disease recurrence despite pathologic response to neoadjuvant ipilimumab plus nivolumab in stage III melanoma.

CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma.

Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study.

Reanalysis of in vivo drug synergy validation study rules out synergy in most cases.

Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.

Quantifying cumulative circadian disruption from shift work and associations with health outcomes in a large cohort of nurses.

Association of ageing-related biomarkers with peripheral neuropathy in colorectal cancer patients up to 2 years after diagnosis.

Microbial metabolic pathways guide response to immune checkpoint blockade therapy.

Image-guided biopsy of breast lesions-when to use what biopsy technique.

Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial.

Coordinated control of genome-nuclear lamina interactions by topoisomerase 2B and lamin B receptor.

DNA polymerase kappa is the primary translesion synthesis polymerase for aldehyde ICLs.

Perspectives on the treatment of sequela from cancer: a qualitative interview study of primary care physiotherapists.

Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape.

A 3D genome compendium of breast cancer progression.

Protocol for multiplexed transcription factor activity detection using optimized barcoded reporters and an automated computational pipeline.

Functional maps of a genomic locus reveal confinement of an enhancer by its target gene

Functional maps of a genomic locus reveal confinement of an enhancer by its target gene.

Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.

The integrin odyssey - a journey full of fundamental discoveries.

Optimising Diagnostic Pathways through digital Multidisciplinary Team management of Patients with Cancer of Unknown Primary: a Retrospective Analysis.

The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma.

'What Really Goes on in My Cancer Bubble, They Cannot Understand': Social Functioning Among Adolescent and Young Adult (AYA) Cancer Patients.

BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants.

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Associations of adherence to the World Cancer Research Fund lifestyle recommendations with health-related quality of life and fatigue in Adolescent and Young Adult (AYA) cancer survivors: results from the SURVAYA study.

Profiling BRCA1-BRCT interactions and their functional relevance at amino acid resolution.

Prognosis and biological characteristics of ER-low metastatic breast cancer: results from a multicenter cohort and the TONIC trial.

Routine annual imaging does not aid in diagnosing new functional complications more than five years after RC with ileal conduit.

Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial.

Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer.

The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.

Night Shift Work and Risk of Melanoma: A Prospective Cohort Study among 59,384 Female Nurses in the Netherlands.

Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.

Comprehensive analysis of the systemic immune landscape across breast cancer subtypes and disease stages.

Exercise oncology comes of age.

NASP modulates histone turnover to drive PARP inhibitor resistance.

Unlocking the signaling potential of GPI-anchored proteins through lipolytic cleavage.

Comparing adaptive and dose redistributed radiotherapy to conventional radiotherapy in head and neck cancer - Quality of life results from the phase III ARTFORCE trial.

This site uses cookies